The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

NCT06606821 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Coronary Microvascular Dysfunction
Overweight or Obesity
Stable Angina Pectoris
Chronic Coronary Artery Disease
Atherosclerosis Cardiovascular Disease

Interventions

DRUG: Tirzepatide
DRUG: Placebo

Sponsor

Tina Vilsbøll